Menu
News
KeyZell revolutionizes the fight against lung and breast cancer with an Artificial Intelligence tool
The Spanish biotechnology startup KeyZell, in alliance with the technology company Iakan, has presented an Artificial Intelligence solution capable of recommending personalized treatments for lung …
KeyZell start-up plans to reach 5 million euros in private investment and become the new biotech unicorn
MADRID, March 17, 2022 /CNW/ — KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, has just opened a private financing …
Starving glioblastoma, the deadliest brain cancer
Glioblastoma is one of the most common, deadly and difficult to treat brain tumors in adults, only 25% of patients survive more than one year. …
Precision medicine against cancer: create the most appropriate treatments for each patient with AI
KeyZell develops novel oncology drugs and finds the most efficient combination of treatments according to each genetics and clinical history. Covid-19 placed the importance of …
Keyzell and Lãberit join forces to develop artificial intelligence to personalize cancer treatments
Madrid, February 18, 2022. KeyZell, a Spanish biotechnology company focused on the discovery and development of a new generation of anticancer drugs, as well as …
Risks of investing in cryptoassets
1. Risks There are many risks involved with a token, some of which are listed below, and there may be others as well. These risks …
